When measuring the association between an exposure and disease, one mu
st decide whether to account for confounding or modifying variables wh
ose levels are altered by the presence of the exposure. For example, t
o assess the impact of cessation of unopposed estrogen therapy on the
occurrence of endometrial cancer, a researcher needs to consider the d
uration of the estrogen therapy, a strong risk factor for endometrial
cancer, as a potential confounder or effect modifier. Duration of estr
ogen therapy, however, is itself influenced by the decision to stop th
e therapy (the ''exposure'' of interest). In such a case, two distinct
approaches may be taken, depending upon the question being considered
. One may wish to assess the degree to which the exposure predicts dis
ease incidence, over and above the additional variable, at some later
point in time. In this case, it is appropriate re, consider the value
of the other variable (for example, duration) at that later time. On t
he other hand, one may also wish to measure the rate of disease beginn
ing at the time of cessation of the exposure, relative to the correspo
nding rate in persons with continuing exposure. Here, the most appropr
iate analysis considers the level of the confounding variable (for exa
mple, duration) measured only until the time the exposure of interest
occurs (for example, cessation of unopposed estrogen therapy). Example
s are given to illustrate that the specific question being addressed d
ictates the handling of covariates of this type.